Enalapril Maleate Prices

Enalapril Maleate Price Trend, Index and Forecast

Track the latest insights on enalapril maleate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Enalapril Maleate Prices Outlook Q1 2026

• USA: USD 99941/MT
• China: USD 159361/MT
• Germany: USD 190405/MT
• India: USD 186807/MT
• Brazil: USD 142838/MT

Enalapril Maleate Price Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the first quarter of 2026, the enalapril maleate prices in the USA reached 99941 USD/MT in March. Prices moved upward as downstream demand from generic drug manufacturers remained firm, supported by steady requirements from antihypertensive formulation producers. Buyers maintained active procurement to secure supply continuity, as regulated pharmaceutical production required consistent availability of qualified active pharmaceutical ingredients.

During the first quarter of 2026, the enalapril maleate prices in China reached 159361 USD/MT in March. Prices increased as domestic active pharmaceutical ingredient producers faced steady offtake from formulation manufacturers and export oriented buyers. Demand from generic medicine production supported pricing, while suppliers remained cautious in offering discounts due to compliance, documentation, and batch certification requirements. 

During the first quarter of 2026, the enalapril maleate prices in Germany reached 190405 USD/MT in March. Prices rose as the market remained influenced by strict regulatory expectations, high quality control costs, and stable demand from finished dosage manufacturers. Buyers preferred certified material from reliable suppliers, which supported premium pricing. Demand from cardiovascular drug manufacturers was consistent, while limited substitution options for approved pharmaceutical inputs strengthened seller positions.

During the first quarter of 2026, the enalapril maleate prices in India reached 186807 USD/MT in March. Prices strengthened as domestic formulation manufacturers maintained steady procurement for antihypertensive medicines. India continued to benefit from a large generic drug manufacturing base, which supported active demand for qualified active pharmaceutical ingredients. The market also reflected stronger sentiment from distributors, who maintained inventories to serve domestic and overseas formulation demand.

During the first quarter of 2026, the enalapril maleate prices in Brazil reached 142838 USD/MT in March. Prices increased as the market remained dependent on imported active pharmaceutical ingredients for cardiovascular formulations. Import costs, currency related procurement pressure, and supplier documentation requirements supported firmer pricing. These factors allowed suppliers to sustain higher offers, leading to a positive price movement during the quarter.

Enalapril Maleate Prices Outlook Q3 2025

• USA: USD 93994/MT
• China: USD 160808/MT
• Germany: USD 188807/MT
• India: USD 185000/MT
• Brazil: USD 135500/MT

During the third quarter of 2025, the enalapril maleate prices in the USA reached 93994 USD/MT in September. Prices moved upward, supported by steady demand from the pharmaceutical formulation sector and tighter availability of API-grade material. Procurement activity remained consistent among generic drug manufacturers, while regulatory compliance requirements and quality validation processes influenced supplier selection and sourcing strategies.

During the third quarter of 2025, the enalapril maleate prices in China reached 160808 USD/MT in September. Prices edged upward, influenced by firm export demand and controlled production output among key manufacturers. Domestic supply remained adequate, while overseas inquiries from regulated markets supported offtake. Inventory management and batch-level production planning played an important role in shaping market activity.

During the third quarter of 2025, the enalapril maleate prices in Germany reached 188807 USD/MT in September. Prices moved lower, reflecting cautious procurement behavior from downstream pharmaceutical companies. Import availability from Asian suppliers ensured sufficient supply coverage. Buyers focused on inventory optimization, regulatory documentation, and cost control when finalizing procurement decisions.

During the third quarter of 2025, the enalapril maleate prices in India reached 185000 USD/MT in September. Prices rose, supported by stable domestic demand from finished dosage manufacturers and consistent export orders. Production levels remained aligned with contract requirements, while buyers emphasized quality certifications and supply reliability. Raw material sourcing and compliance costs influenced production planning.

During the third quarter of 2025, the enalapril maleate prices in Brazil reached 135500 USD/MT in September. Prices moved upward, driven by steady demand from local pharmaceutical formulators. Import reliance shaped availability, while distributors focused on managing lead times and regulatory approvals. Procurement strategies emphasized supply continuity and quality assurance.

Enalapril Maleate Prices Outlook Q2 2025

• USA: USD 87681/MT
• China: USD 157347/MT
• Germany: USD 191294/MT
• India: USD 182987/MT
• Brazil: USD 133893/MT

During the second quarter of 2025, the enalapril maleate prices in the USA reached 87681 USD/MT in June. Demand from generic drug manufacturers remained consistent. Import flows supported availability, while buyers focused on contract-based procurement and regulatory compliance. Inventory planning and supplier qualification influenced sourcing decisions.

During the second quarter of 2025, the enalapril maleate prices in China reached 157347 USD/MT in June. Domestic production ensured sufficient supply for both local and export markets. Demand from regulated export destinations remained steady. Manufacturers managed output in line with confirmed orders, while inventory discipline shaped market transactions.

During the second quarter of 2025, the enalapril maleate prices in Germany reached 191294 USD/MT in June. Consumption from pharmaceutical formulation companies remained stable. Import availability supported procurement needs, while buyers prioritized quality documentation and regulatory alignment. Purchasing decisions were largely contract-driven.

During the second quarter of 2025, the enalapril maleate prices in India reached 182987 USD/MT in June. Domestic demand from formulation units supported regular offtake. Export activity remained steady, while manufacturers aligned production with contractual obligations. Compliance requirements and raw material sourcing influenced procurement planning.

During the second quarter of 2025, the enalapril maleate prices in Brazil reached 133893 USD/MT in June. Consistent demand from local pharmaceutical producers was a key trend. Import dependence influenced supply availability, while distributors focused on managing regulatory clearances and delivery schedules. Inventory control remained a key procurement consideration.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing enalapril maleate prices.

Europe Enalapril Maleate Price Trend

Q1 2026:

The enalapril maleate price index in Europe moved upward as pharmaceutical buyers prioritized reliable supply from qualified producers. Demand from generic formulation manufacturers remained steady, supported by regular production of antihypertensive medicines. Prices were influenced by strict compliance requirements, testing expenses, documentation standards, and higher operating costs across regulated pharmaceutical supply chains. Buyers showed limited interest in risky low cost alternatives because approved sourcing remains important for finished dosage production.

Q3 2025:

As per the enalapril maleate price index, European pricing conditions, as reflected in Germany, registered a decline. Pharmaceutical formulation companies adjusted procurement cautiously amid sufficient import availability from Asian suppliers. Regulatory compliance requirements, batch traceability, and documentation standards strongly influenced sourcing decisions. Buyers emphasized inventory optimization, supplier qualification, and cost discipline, while audit readiness and lead-time management shaped procurement behavior across regulated European markets.

Q2 2025:

European market fundamentals reflected balanced supply-demand conditions. Demand from pharmaceutical formulation units supported regular material offtake across the region. Import availability ensured adequate supply coverage, while procurement activity remained largely contract-driven. Buyers focused on quality compliance, documentation completeness, and inventory planning aligned with formulation and regulatory schedules.

This analysis can be extended to include detailed enalapril maleate price information for a comprehensive list of countries.

North America Enalapril Maleate Price Trend

Q1 2026:

The enalapril maleate price index in North America strengthened as generic drug manufacturers maintained active procurement for cardiovascular formulations. The USA market reflected firmer sentiment due to steady downstream demand, supplier qualification needs, and reliance on imported active pharmaceutical ingredients. Buyers placed value on documentation quality, regulatory consistency, and delivery reliability, which limited aggressive price negotiations. Contract manufacturers and distributors continued to secure material from approved suppliers to avoid disruption in regulated medicine production.

Q3 2025:

As per the enalapril maleate price index, pricing levels in North America moved higher, as observed in the USA. Demand from generic drug manufacturers supported procurement activity, while import reliance influenced supply planning and lead-time management. Distributors and formulators prioritized inventory replenishment cycles, regulatory adherence, and supplier performance monitoring to maintain continuity in downstream pharmaceutical production.

Q2 2025:

Market conditions in North America reflected steady pharmaceutical manufacturing demand. Import flows supported formulation requirements, while procurement strategies emphasized contract stability and predictable delivery performance. Buyers focused on inventory alignment with production schedules, quality assurance protocols, and regulatory compliance across the supply chain.

Specific enalapril maleate historical data within the United States and Canada can also be provided.

Middle East and Africa Enalapril Maleate Price Trend

Q1 2026:

The enalapril maleate price index in North America strengthened as generic drug manufacturers maintained active procurement for cardiovascular formulations. The USA market reflected firmer sentiment due to steady downstream demand, supplier qualification needs, and reliance on imported active pharmaceutical ingredients. Buyers placed value on documentation quality, regulatory consistency, and delivery reliability, which limited aggressive price negotiations. Contract manufacturers and distributors continued to secure material from approved suppliers to avoid disruption in regulated medicine production.

Q3 2025:

As per enalapril maleate price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q2 2025:

The report explores the enalapril maleate pricing trends and enalapril maleate price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on enalapril maleate prices for countries can also be provided.

Asia Pacific Enalapril Maleate Price Trend

Q1 2026:

In the Asia Pacific, enalapril maleate prices increased, supported by strong activity in major pharmaceutical manufacturing centers. China and India showed firm market conditions as domestic formulation demand and export oriented procurement supported active buying. Producers benefited from steady orders from generic medicine manufacturers, particularly those serving cardiovascular therapy segments. Quality requirements, compliance testing, and validated supplier relationships kept pharmaceutical grade pricing firm.

Q3 2025:

In the Asia Pacific region, pricing trends reflected upward movement in China and India. Export demand from regulated destinations supported offtake, while domestic consumption from formulation units remained consistent. Production planning, inventory management, and compliance requirements influenced supply distribution. Buyers emphasized batch consistency, regulatory alignment, and delivery reliability across inter-regional trade flows.

Q2 2025:

Regional market conditions reflected steady operational activity across pharmaceutical manufacturing hubs. Domestic production and export-oriented output ensured adequate availability for downstream formulators. Procurement strategies centered on maintaining supply continuity, managing inventories efficiently, and aligning sourcing with manufacturing schedules and compliance requirements.

This enalapril maleate price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Enalapril Maleate Price Trend

Q1 2026:

In Latin America, enalapril maleate prices trended upward as import dependent markets faced firm landed costs and steady pharmaceutical demand. Brazil reflected the regional pattern, with buyers relying on approved international suppliers for active pharmaceutical ingredient supply. Demand from generic cardiovascular formulations remained stable, as antihypertensive medicines are a routine requirement across public and private healthcare channels. Import documentation, logistics charges, currency movement, and supplier qualification costs influenced procurement values.

Q3 2025:

In Latin America, pricing levels increased, as reflected in Brazil. Demand from domestic pharmaceutical formulators supported procurement activity, while import reliance influenced supply planning and logistics coordination. Distributors focused on regulatory approvals, inventory planning, and supplier reliability to support downstream manufacturing requirements in import-dependent markets.

Q2 2025:

Market conditions reflected consistent pharmaceutical manufacturing demand. Import flows supported formulation activity across the region, while buyers emphasized contract adherence, quality compliance, and delivery coordination. Procurement decisions focused on inventory discipline and uninterrupted supply to meet production requirements.

This comprehensive review can be extended to include specific countries within the region.

Enalapril Maleate Pricing Report, Market Analysis, and News

IMARC's latest publication, “Enalapril Maleate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the enalapril maleate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of enalapril maleate at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed enalapril maleate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting enalapril maleate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Enalapril Maleate Industry Analysis

The global enalapril maleate industry size reached USD 595.6 Million in 2025. By 2034, IMARC Group expects the market to reach USD 893.0 Million, at a projected CAGR of 4.60% during 2026-2034. Market growth is driven by sustained demand for antihypertensive medications, increasing prevalence of cardiovascular disorders, and continued production of generic formulations across regulated and emerging pharmaceutical markets.

Latest News and Developments:

• May 2025: Senores Pharmaceuticals Limited announced that its US subsidiary, Senores Pharmaceuticals, Inc., USA, entered into a definitive agreement with Wockhardt Limited to acquire the US FDA-approved Abbreviated New Drug Application (ANDA) for enalapril maleate tablets. The acquired ANDA covers multiple strengths of enalapril maleate tablets and enables Senores to commercialize the product in the United States, strengthening its regulated-market generics portfolio in the cardiovascular therapy segment.

Product Description

Enalapril maleate is a medication used to treat high blood pressure and congestive heart failure. It belongs to the angiotensin-converting enzyme (ACE) inhibitors class and relaxes blood vessels, facilitating smooth blood flow and enhancing the heart's ability to pump blood. This medicine is mostly taken orally, either with or without food, and is available in tablet form.

It is commonly prescribed for hypertension management, lowering blood pressure, and reducing the risk of heart attacks, strokes, and kidney problems. In congestive heart failure, it improves symptoms like shortness of breath and swelling in the legs. However, enalapril maleate is not recommended for use during pregnancy due to potential harm to the unborn baby and may interact with certain medications, so it is crucial to inform healthcare providers of all medications, supplements, and herbal products being taken.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of enalapril maleate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting enalapril maleate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The enalapril maleate price charts ensure our clients remain at the forefront of the industry.